{
    "organizations": [],
    "uuid": "309bc7c5f12d798d7549f5e8eb5f7d673c53a060",
    "author": "",
    "url": "https://www.reuters.com/article/brief-opiant-pharmaceuticals-awarded-gra/brief-opiant-pharmaceuticals-awarded-grant-of-approximately-7-4-mln-from-the-national-institutes-of-health-idUSFWN1RV0FM",
    "ord_in_thread": 0,
    "title": "BRIEF-Opiant Pharmaceuticals Awarded Grant Of Approximately $7.4 Mln From The National Institutes Of Health",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 18, 2018 / 12:10 PM / Updated 10 minutes ago BRIEF-Opiant Pharmaceuticals Awarded Grant Of Approximately $7.4 Mln From The National Institutes Of Health Reuters Staff 1 Min Read \nApril 18 (Reuters) - Opiant Pharmaceuticals Inc: \n* OPIANT PHARMACEUTICALS AWARDED GRANT OF APPROXIMATELY $7.4 MILLION FROM THE NATIONAL INSTITUTES OF HEALTH FOR DEVELOPMENT OF OPNT003, INTRANASAL NALMEFENE, FOR TREATMENT OF OPIOID OVERDOSE \n* OPIANT PHARMACEUTICALS-GRANT INCLUDES ABOUT $2.6 MILLION TO BE FUNDED FOR PERIOD ENDING MARCH 31, 2019, WITH BALANCE TO BE FUNDED OVER SUBSEQUENT 2 YEARS Source text for Eikon: Further company coverage:",
    "published": "2018-04-18T15:09:00.000+03:00",
    "crawled": "2018-04-18T15:30:31.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "pm",
        "updated",
        "minute",
        "ago",
        "pharmaceutical",
        "awarded",
        "grant",
        "approximately",
        "mln",
        "national",
        "institute",
        "health",
        "reuters",
        "staff",
        "min",
        "read",
        "april",
        "reuters",
        "opiant",
        "pharmaceutical",
        "inc",
        "opiant",
        "pharmaceutical",
        "awarded",
        "grant",
        "approximately",
        "million",
        "national",
        "institute",
        "health",
        "development",
        "opnt003",
        "intranasal",
        "nalmefene",
        "treatment",
        "opioid",
        "overdose",
        "opiant",
        "includes",
        "million",
        "funded",
        "period",
        "ending",
        "march",
        "balance",
        "funded",
        "subsequent",
        "year",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}